Name | SR 2640 hydrochloride |
---|---|
Synonyms |
2-{[3-(2-Quinolinylmethoxy)phenyl]amino}benzoic acid hydrochloride (1:1)
2-{[3-(Quinolin-2-ylmethoxy)phenyl]amino}benzoic acid hydrochloride (1:1) Benzoic acid, 2-[[3-(2-quinolinylmethoxy)phenyl]amino]-, hydrochloride (1:1) MFCD04971976 |
Description | SR2640 (hydrochloride) is a potent and selective competitive leukotriene D4/leukotriene E4 antagonist. SR2640 can be used for researching the role of leukotrienes in human asthma[1]. |
---|---|
Related Catalog | |
Target |
LTD4 and LTE4[1] |
In Vivo | SR2640 inhibits the LTD 4-induced contractions of guinea-pig ileum in a concentration-dependent manner, with an IC50 of 3 nM[1]. SR2640 (1 mg/kg; IV; single dosage) specifically prevents the contractile responses of guinea-pig ileum and trachea to LTD4 and LTE4[1]. Animal Model: Guinea pigs (injected with LTD4 and LTE4)[1] Dosage: 1 mg/kg Administration: IV; single dosage Result: Specifically prevented the contractile responses of guinea-pig ileum and trachea to LTD4 and LTE4. |
References |
Molecular Formula | C23H19ClN2O3 |
---|---|
Molecular Weight | 406.86 |
Exact Mass | 406.108429 |